ATE219688T1 - Liposomen enthaltend ein röntgen- oder ultraschallkontrastmittel - Google Patents

Liposomen enthaltend ein röntgen- oder ultraschallkontrastmittel

Info

Publication number
ATE219688T1
ATE219688T1 AT95913223T AT95913223T ATE219688T1 AT E219688 T1 ATE219688 T1 AT E219688T1 AT 95913223 T AT95913223 T AT 95913223T AT 95913223 T AT95913223 T AT 95913223T AT E219688 T1 ATE219688 T1 AT E219688T1
Authority
AT
Austria
Prior art keywords
liposomes
ray
imaging agent
contrast agent
liposomes containing
Prior art date
Application number
AT95913223T
Other languages
English (en)
Inventor
Jo Klaveness
Arne Berg
Trond Vegard Jacobsen
Pal Rongved
Thorfinn Ege
Hiroshi Kikuchi
Kiyoto Yachi
Original Assignee
Nycomed Imaging As
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As, Daiichi Seiyaku Co filed Critical Nycomed Imaging As
Application granted granted Critical
Publication of ATE219688T1 publication Critical patent/ATE219688T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT95913223T 1994-03-28 1995-03-27 Liposomen enthaltend ein röntgen- oder ultraschallkontrastmittel ATE219688T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5748094 1994-03-28
PCT/GB1995/000689 WO1995026205A1 (en) 1994-03-28 1995-03-27 Liposomes

Publications (1)

Publication Number Publication Date
ATE219688T1 true ATE219688T1 (de) 2002-07-15

Family

ID=13056884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95913223T ATE219688T1 (de) 1994-03-28 1995-03-27 Liposomen enthaltend ein röntgen- oder ultraschallkontrastmittel

Country Status (10)

Country Link
US (1) US5676928A (de)
EP (1) EP0752889B1 (de)
CN (1) CN1148812A (de)
AT (1) ATE219688T1 (de)
AU (1) AU2076895A (de)
CA (1) CA2185810A1 (de)
DE (1) DE69527194T2 (de)
IL (1) IL113139A0 (de)
WO (1) WO1995026205A1 (de)
ZA (1) ZA952485B (de)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5469854A (en) 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US6217849B1 (en) 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
ES2165971T3 (es) * 1995-02-24 2002-04-01 Bracco Research Sa Suspensiones de liposomas como agentes de contraste para la imagineria de la sangre.
US5997898A (en) 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
GB9519654D0 (en) * 1995-09-27 1995-11-29 Nycomed Imaging As Stabilised phospholipid compositions
CA2252617A1 (en) 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
JP3634869B2 (ja) * 1996-08-02 2005-03-30 アメルシャム ヘルス アクスイェ セルスカプ 造影剤における又はこれに関する改良
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
ES2189974T3 (es) 1996-09-11 2003-07-16 Imarx Pharmaceutical Corp Procedimientos mejorados para la obtencion de imagenes de diagnostico usando un agente de contraste y un vasodilatador.
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
GB9624918D0 (en) * 1996-11-29 1997-01-15 Nycomed Imaging As Particulate components
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6005083A (en) * 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6392264B2 (en) * 1997-07-08 2002-05-21 Hideki Takeuchi Semiconductor memory device and method of producing the same
US6001333A (en) * 1997-09-12 1999-12-14 See; Jackie R. Methods of preparing micro encapsulated agents for use in the detection of tumors by CT imaging
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US8974363B2 (en) 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
RU2207808C2 (ru) * 1998-04-09 2003-07-10 Амершем Хелт АС Применение контрастных агентов в форме частиц в диагностической визуализации для изучения физиологических параметров
WO1999061001A1 (en) 1998-05-29 1999-12-02 Rtp Pharma Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
US8557298B2 (en) 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20040047804A1 (en) * 1998-10-29 2004-03-11 The General Hospital Corporation, A Massachusetts Corporation Enhanced radiation therapy
WO2000030616A1 (en) 1998-11-20 2000-06-02 Rtp Pharma Inc. Dispersible phospholipid stabilized microparticles
US6203778B1 (en) 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US6351663B1 (en) 1999-09-10 2002-02-26 Akorn, Inc. Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
CA2405469C (en) 2000-04-12 2012-03-20 Amersham Health As Integrin binding peptide derivatives
US20030124180A1 (en) * 2000-05-02 2003-07-03 Jurgen Ebert Liposomes containing active substances
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
AU2002313616A1 (en) 2001-07-10 2003-01-29 Amersham Health As Peptide-based compounds for targeting intergin receptors
US7008614B2 (en) * 2001-08-20 2006-03-07 Fuji Photo Film Co., Ltd. Liposome containing hydrophobic iodine compound and X-ray contrast medium for radiograph comprising the liposome
DE10148065A1 (de) * 2001-09-28 2003-04-17 Max Planck Gesellschaft (Ester)-Lysolecithine in Liposomen
EP1331012A1 (de) 2002-01-29 2003-07-30 BRACCO IMAGING S.p.A. Magnetisch beeinflussbare paramagnetische Kontrastmittel für Magnetresonanzbildgebung
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
US20040213837A1 (en) * 2002-08-05 2004-10-28 Sankaram Mantripragada Oil-core compositions for the sustained release of hydrophobic drugs
US8980310B2 (en) * 2002-12-31 2015-03-17 Bharat Serums and Vaccines, Ltd. Non-pegylated long-circulating liposomes
JP2005170923A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法
CN1321697C (zh) * 2003-12-23 2007-06-20 中国人民解放军军事医学科学院毒物药物研究所 一种以磷脂类成分为成膜材料的超声造影剂组合物及其制备方法
WO2005063304A2 (en) * 2003-12-24 2005-07-14 Board Of Regents, The University Of Texas_System Poly (l-glutamic acid) paramagnetic material complex and use as a biodegradable mri contrast agent
US7713517B2 (en) * 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
WO2006009022A1 (ja) * 2004-07-21 2006-01-26 Konica Minolta Medical & Graphic, Inc. リポソーム含有ｘ線造影剤およびその製造方法
CN100574811C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用微粒类助剂及其应用
CN100574809C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
CN100427142C (zh) * 2005-01-10 2008-10-22 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用助剂及其筛选方法
US8703097B2 (en) * 2005-02-11 2014-04-22 University Health Network Compositions and method for multimodal imaging
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2006100692A2 (en) * 2005-03-21 2006-09-28 Lifecare Innovations Pvt. Ltd. A novel inter and intra multilamellar vesicular composition.
KR20080009682A (ko) * 2005-04-01 2008-01-29 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 킬레이트제인 폴리(펩티드): 제조 방법과 용도
NO20052428D0 (no) * 2005-05-20 2005-05-20 Amersham Health As Kontrastmidler
NO20052429D0 (no) * 2005-05-20 2005-05-20 Amersham Health As Konstrastmidler
WO2007088051A2 (en) 2006-01-31 2007-08-09 Bayer Schering Pharma Aktiengesellschaft Modulation of mdl-1 activity for treatment of inflammatory disease
HUE030903T2 (en) * 2006-04-25 2017-06-28 Univ California Administration of growth factors for the treatment of CNS disorders
JP2009535360A (ja) * 2006-04-26 2009-10-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 高分子量神経治療薬の対流増加送達のための組成物および方法
WO2007129311A2 (en) * 2006-05-04 2007-11-15 Pan Sci Tech S.A. Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
EP2842570B1 (de) * 2007-03-07 2020-05-06 UTI Limited Partnership Zusammensetzungen und verfahren zur prävention und behandlung von autoimmunkrankheiten
KR100921959B1 (ko) * 2007-06-04 2009-10-15 바이오스펙트럼 주식회사 다중층 리포좀 및 단일막 나노 리포좀을 포함하는다중-유화 베시클
WO2009073236A1 (en) 2007-12-05 2009-06-11 Marval Biosciences, Inc. Nano-scale contrast agents and methods of use
US20090311191A1 (en) * 2008-06-13 2009-12-17 Ananth Annapragada Imaging of atherosclerotic plaques using liposomal imaging agents
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
CA2781527C (en) 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes
US10894098B2 (en) 2012-04-09 2021-01-19 Signablok, Inc. Methods and compositions for targeted imaging
US12419839B2 (en) 2009-10-09 2025-09-23 Signablok, Inc. Methods and compositions for targeted delivery of protein fragments
WO2011044545A2 (en) 2009-10-09 2011-04-14 Sigalov Alexander B Methods and compositions for targeted imaging
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
DK2694116T3 (en) 2011-04-06 2018-09-03 Univ Texas LIPID-BASED NANOPARTICLES
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
BR112014010879A2 (en) 2012-01-20 2017-06-13 Annapragada Ananth methods and compositions for objectively characterizing medical images
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
WO2013151650A1 (en) * 2012-04-05 2013-10-10 University Of Florida Research Foundation, Inc. Neurophilic nanoparticles
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
WO2014144708A1 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
SG10201912301XA (en) 2013-11-04 2020-02-27 Uti Lp Methods and compositions for sustained immunotherapy
WO2015148985A1 (en) * 2014-03-28 2015-10-01 The Regents Of The University Of California Liposomal drug encapsulation
MX371295B (es) 2014-10-08 2020-01-24 Texas Childrens Hospital Formación de imágenes por irm de placas amiloides usando liposomas.
EP3240579B1 (de) 2014-12-31 2022-07-27 Lantheus Medical Imaging, Inc. Lipidverkapselte gasmikrosphärenzusammensetzungen und zugehörige verfahren
JP6920211B2 (ja) 2015-05-06 2021-08-18 ユーティーアイ リミテッド パートナーシップ 持続療法用のナノ粒子組成物
CN115531560B (zh) 2016-05-04 2024-05-17 蓝瑟斯医学影像公司 用于制备超声波造影剂的方法及装置
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
EP3412303A1 (de) 2017-06-08 2018-12-12 Medizinische Universität Innsbruck Verbessertes pharmakokinetik- und cholecystokinin-2-rezeptor (cck2r)-zielverfahren für diagnose und therapie
JP7436372B2 (ja) 2017-11-29 2024-02-21 ユーティアイ・リミテッド・パートナーシップ 自己免疫性疾患を治療する方法
CN112138173A (zh) * 2020-10-26 2020-12-29 山东源科生物科技股份有限公司 一种胃肠超声造影剂及其制备方法
WO2023076220A1 (en) * 2021-10-25 2023-05-04 Board Of Regents, The University Of Texas System Conjugates having antifouling nanoparticles and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
CH641682A5 (en) * 1978-10-05 1984-03-15 Daeniker Felix X-ray contrast medium
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4900540A (en) * 1983-06-20 1990-02-13 Trustees Of The University Of Massachusetts Lipisomes containing gas for ultrasound detection
US4863717A (en) * 1986-11-10 1989-09-05 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging
CH672733A5 (de) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
WO1989011272A1 (en) * 1988-05-20 1989-11-30 The Liposome Company, Inc. High ratio active agent:lipid complex
JPH04501723A (ja) * 1988-11-09 1992-03-26 アンガー，エヴァン，シー． リポソーム性放射線造影剤
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5228446A (en) * 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
JP3131923B2 (ja) * 1990-01-12 2001-02-05 ザ リポソーム カンパニー，インコーポレイテッド 指状突起―融合リポソームおよびゲル
DE4013580A1 (de) * 1990-04-24 1991-10-31 Schering Ag Verfahren zur herstellung von wirkstoffhaltigen waessrigen liposomensuspensionen
IS1685B (is) * 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
WO1992011840A1 (de) * 1991-01-07 1992-07-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Kontrastmittel für die mr-diagnostik
GB9106673D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents

Also Published As

Publication number Publication date
EP0752889A1 (de) 1997-01-15
ZA952485B (en) 1995-12-15
CA2185810A1 (en) 1995-10-05
CN1148812A (zh) 1997-04-30
EP0752889B1 (de) 2002-06-26
IL113139A0 (en) 1995-06-29
DE69527194D1 (de) 2002-08-01
US5676928A (en) 1997-10-14
DE69527194T2 (de) 2003-02-06
WO1995026205A1 (en) 1995-10-05
AU2076895A (en) 1995-10-17

Similar Documents

Publication Publication Date Title
ATE219688T1 (de) Liposomen enthaltend ein röntgen- oder ultraschallkontrastmittel
US4192859A (en) Contrast media containing liposomes as carriers
DE68915001T2 (de) Liposome.
Zheng et al. In vivo performance of a liposomal vascular contrast agent for CT and MR-based image guidance applications
RU2207808C2 (ru) Применение контрастных агентов в форме частиц в диагностической визуализации для изучения физиологических параметров
ATE99544T1 (de) Liposomale radiologische kontrastmittel.
BR9708470A (pt) Agentes de contraste bioativados para formação de imagem para diagnósticos
HU221805B1 (hu) Vas-oxid részecskék NMR-spektrum felvételéhez és eljárás ezek előállítására
AU4918896A (en) Nanoparticulate diagnostic dimers as x-ray contrast agents for blood pool and lymphatic system imaging
PL309395A1 (en) Injectable aqueous preparations useful in x-ray diagnostics, containing iodised aromatic compounds used as x-raying contrast media
EP1848464B1 (de) Zusammensetzungen und verfahren zur multimodalen bildgebung
CL2004001126A1 (es) Complejos de polimeros en cascada y sus composiciones farmaceuticas, utiles para la preparacion de agentes de diagnostico por nmr.
ATE287700T1 (de) Strahlung-sensitive liposomen
EP1706145A4 (de) Bei tumorbildgebung und krebsbehandlung als trägermittel für pharmazeutische verbindungen eingesetzte autoantikörper
CA1333359C (en) Dental therapy by vesicle delivery
NO940115D0 (no) Kontrastmidler for roentgen- og magnettomografisk avbildning
NO965301D0 (no) 2,4,6-trijod-5-substituerte-amino-isoftalatestere nyttige som röntgenkontrastmidler for medisinsk diagnostisk billeddannelse
CN100506286C (zh) 用于鉴定前哨淋巴结的方法、化合物和制剂
Fink et al. Lipid emulsions as contrast agents for hepatic sonography: an experimental study in rabbits
NO973666D0 (no) Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom
JP2852902B2 (ja) Ｍｒｉ装置の撮影トレーニング用人体ファントム
RU94000719A (ru) Алкилбензолы, композиции, содержащие алкилбензолы для визуализации желудочно-кишечного тракта, способ исследования желудочно-кишечного тракта
DK0759785T3 (da) Liposomsuspensioner som blodkontrastmidler
NO963942L (no) Liposomer inneholdende kontrastmidler
Tweedle Nonionic or neutral?